Literature DB >> 18194287

Memantine and NMDA antagonism for chronic migraine: a potentially novel therapeutic approach?

Konstantinos Spengos1, Christos Theleritis, Thomas Paparrigopoulos.   

Abstract

We present the case of a woman with chronic migraine who unexpectedly reported full remission of headache after memantine, an NMDA receptor antagonist, was administered for treating concomitant mild cognitive impairment. An underlying dose-dependent effect of memantine on headache symptoms in chronic daily headache and chronic migraine could be assumed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18194287     DOI： 10.1111/j.1526-4610.2007.01016.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


  8 in total

1.  Memantine for the prophylaxis of chronic tension-type headache.

Authors:  Katherine A Henry
Journal:  Curr Pain Headache Rep       Date:  2009-12

Review 2.  Chronic Daily Headache: Mechanisms and Principles of Management.

Authors:  Amy W Voigt; Harry J Gould
Journal:  Curr Pain Headache Rep       Date:  2016-02

3.  The Antinociceptive Effect of Sigma-1 Receptor Antagonist, BD1047, in a Capsaicin Induced Headache Model in Rats.

Authors:  Young Bae Kwon; Young Chan Jeong; Jung Kee Kwon; Ji Seon Son; Kee Won Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

4.  Chronic daily headaches.

Authors:  Fayyaz Ahmed; Rajsrinivas Parthasarathy; Modar Khalil
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

5.  N-Methyl-d-aspartate receptor open-channel blockers memantine and magnesium modulate nociceptive trigeminovascular neurotransmission in rats.

Authors:  Jan Hoffmann; Robin James Storer; Jeong-Wook Park; Peter J Goadsby
Journal:  Eur J Neurosci       Date:  2019-06-03       Impact factor: 3.698

6.  Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model.

Authors:  Pernille Bøttger; Simon Glerup; Bodil Gesslein; Nina B Illarionova; Toke J Isaksen; Anders Heuck; Bettina H Clausen; Ernst-Martin Füchtbauer; Jan B Gramsbergen; Eli Gunnarson; Anita Aperia; Martin Lauritzen; Kate L Lambertsen; Poul Nissen; Karin Lykke-Hartmann
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

7.  Current migraine management - patient acceptability and future approaches.

Authors:  Arnaud Fumal; Jean Schoenen
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

Review 8.  Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.

Authors:  Zsófia Majláth; Nóra Török; József Toldi; László Vécsei
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.